Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05375994
Title Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients (RAMP204)
Acronym RAMP204
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Thoracic Oncology San Francisco California 94158 United States Details
University of Colorado Hospital Anschutz Cancer Pavllion Aurora Colorado 80045 United States Details
Mayo Clinic Cancer Center Jacksonville Florida 32224 United States Details
Mayo Clinic Cancer Center Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 275514 United States Details
Virginia Cancer Specialists, NEXT Oncology Fairfax Virginia 22031 United States Details
Medical College Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field